Blue Trust Inc. Lowers Holdings in HCA Healthcare, Inc. $HCA

Blue Trust Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 19,161 shares of the company’s stock after selling 4,560 shares during the quarter. Blue Trust Inc.’s holdings in HCA Healthcare were worth $9,068,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in HCA. Fifth Third Wealth Advisors LLC raised its holdings in shares of HCA Healthcare by 11.5% during the first quarter. Fifth Third Wealth Advisors LLC now owns 2,557 shares of the company’s stock valued at $1,210,000 after purchasing an additional 264 shares during the last quarter. OP Asset Management Ltd purchased a new stake in HCA Healthcare during the 1st quarter valued at $12,883,000. Apella Capital LLC lifted its holdings in shares of HCA Healthcare by 93.2% during the 1st quarter. Apella Capital LLC now owns 1,198 shares of the company’s stock valued at $585,000 after buying an additional 578 shares during the period. Weaver Capital Management LLC grew its holdings in shares of HCA Healthcare by 24.9% in the first quarter. Weaver Capital Management LLC now owns 3,126 shares of the company’s stock worth $1,479,000 after acquiring an additional 624 shares during the period. Finally, Cidel Asset Management Inc. lifted its holdings in HCA Healthcare by 7.3% in the first quarter. Cidel Asset Management Inc. now owns 1,467 shares of the company’s stock valued at $694,000 after acquiring an additional 100 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA was highlighted as a top value stock for long-term investors, reinforcing the view that the shares may be attractive based on fundamentals and valuation. Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
• Positive Sentiment: TriStar, part of HCA, received a certificate of need to build a freestanding emergency room in Lebanon, which supports continued facility expansion and local growth. TriStar gains certificate of need to build freestanding ER in Lebanon
• Positive Sentiment: HCA Healthcare Foundation awarded $2.1 million in grants to 89 Middle Tennessee nonprofits, reinforcing community ties and brand goodwill in a core market. 89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation
• Neutral Sentiment: HCA sold 31 home health and hospice agencies, and DAI is acquiring 24 home health agencies from HCA, suggesting ongoing portfolio reshaping but not an obviously major earnings catalyst. HCA sells 31 home health, hospice agencies DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home
• Neutral Sentiment: Coverage on the Frist family and HCA’s history, along with the naming of a new hospital CEO and a healthcare CEO pay list, is largely informational and unlikely to move the stock by itself. Frist family letter reveals the values that built HCA Healthcare by Dr. Thomas Frist Sr. HCA HealthONE names CEO of 2 Denver hospitals 23 highest-paid healthcare CEOs: Wall Street Journal
• Negative Sentiment: HCA’s chief clinical officer is set to exit after four years, creating some leadership turnover at the company. HCA’s chief clinical officer to exit after 4 years

HCA Healthcare Stock Up 0.4%

NYSE HCA opened at $388.38 on Thursday. The business has a 50-day moving average price of $412.73 and a 200-day moving average price of $466.54. The firm has a market cap of $86.16 billion, a price-to-earnings ratio of 13.36, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is currently 10.73%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HCA. Leerink Partners lowered their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. JPMorgan Chase & Co. decreased their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Finally, Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.